UNSPSC 51172340: Calcium folinate

A formyl derivative of tetrahydrofolic acid which is a metabolite and active form of folic acid.

UNSPSC 51172340 Calcium folinate, a Commodity code, shows minimal recent state and local procurement activity directly aligned with its nominal scope. The three recorded opportunities in the source bracket a wider pharmaceutical and laboratory services landscape — offender drug testing, pharmacy benefit management strategy, and generic multi-source pharmaceuticals distribution — but none explicitly solicit calcium folinate or chemotherapy-support pharmaceuticals as a primary line item. The code appears underutilized or misaligned with the actual state and local purchasing patterns visible in current solicitations, which emphasize testing services, benefit-program restructuring, and broad generic drug contracting rather than specialized oncology-support medications.

The most concrete recent opportunity is Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services (due July 23, 2026, estimated contract value $600,000), which focuses on immunoassay screening and confirmation testing unrelated to calcium folinate. The Texas Health and Human Services Commission issued a Request for Information in April 2026 exploring direct-to-manufacturer prescription programs, signaling strategic interest in pharmacy procurement redesign but not calcium folinate specifically. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) posted RFP S1070000015802 in January 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, encompassing a broad product universe but with no evidence of calcium folinate inclusion. Activity is scattered across Texas (Collin County, HHS Commission) and Minnesota (MMCAP, serving multiple states), with no concentration suggesting sustained demand under this code. Business development professionals should verify whether calcium folinate opportunities are tagged under alternative pharmaceutical codes or whether state and local procurement activity for this specialty pharmaceutical remains negligible in the available notice pool.